NCT05634252 Undergraduate Skin Cancer Prevention Trial
| NCT ID | NCT05634252 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | University of Utah |
| Condition | Skin Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 528 participants |
| Start Date | 2023-04-24 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 528 participants in total. It began in 2023-04-24 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study is a Multiphase Optimization Strategy (MOST) that uses factorial experiments to evaluate individual and combined effects of intervention components to improve intervention efficiency. The study team anticipates enrolling a total of 528 undergraduate students (\>18 years) into the trial to identify intervention approaches that eliminate sunburn, and secondarily to motivate sun protection and discourage tanning. The study team will test personalized risk components: 1) UV Photo, 2) Action Plan, and 3) MC1R Testing. A full factorial experiment will be conducted to test which of the proposed components or their combinations eliminate sunburn over one year. The study team will also examine effects of the intervention on secondary outcomes. Study assessments will be completed at 4 time points: baseline, 1-month post-intervention, 4-months post-intervention, and 15-months post-intervention.
Eligibility Criteria
Inclusion Criteria: * At least 18 years old * Enrolled as an undergraduate student * Report having at least one sunburn in the last year, AND/OR having tanned indoors at least once in the last year, AND/OR intentional or unintentional outdoor tanning "sometimes," "often," or "always," AND/OR or using sunscreen plus one or more other sun protection behavior (protective clothing use, shade use when outdoors) infrequently ("never," "seldom," or "sometimes"). Exclusion Criteria: * Do not read or speak English * Self-reported personal history of skin cancer
Contact & Investigator
Yelena Wu, PhD
PRINCIPAL INVESTIGATOR
University of Utah
Frequently Asked Questions
Who can join the NCT05634252 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT05634252 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 528 participants.
Is NCT05634252 currently recruiting?
Yes, NCT05634252 is actively recruiting participants. Contact the research team at Ben.Weitzman@hci.utah.edu for enrollment information.
Where is the NCT05634252 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT05634252 clinical trial?
NCT05634252 is sponsored by University of Utah. The principal investigator is Yelena Wu, PhD at University of Utah. The trial plans to enroll 528 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.